Copeptin in Aortic Valve Replacement

GE DHM-AN-OR-2012/01

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01648647

Acronym

CARE

Enrollment

Registered

2012-07-24

Start date

2012-05-31

Completion date

Unknown

Last updated

2012-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Copeptin in Patients Undergoing Aortic Valve Replacement

Brief summary

Copeptin is accepted as a marker of stress. We want to evaluate the preoperative and early postoperative copeptin leavens in patients undergoing different aortic valve procedures

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients undergoing surgical aortic valve replacment * Patients undergoing transcatheter aortic valve replacment

Exclusion criteria

* denial by patient

Countries

Germany

Outcome results